This is By How Much Alzheimer’s Is Expected to Increase in Idaho

The Food and Drug Administration on Monday approved the first new treatment for Alzheimer’s disease in about 20 years. Currently available Alzheimer’s drugs treat the disease’s symptoms. The newly-approved medicine, called Aduhelm, is the first to attack a substance that could be associated with the underlying causes of the disease — a toxic and sticky protein in the brain called amyloid.

The Alzheimer’s Association estimates that 6.0 million Americans 65 and older were living with the disease as of 2020, or 12% of the 65 and over population. As more and more of the baby boomer generation reaches that age, the number of Americans with the disease will inevitably increase.

The increase in the number of people 65 and over with Alzheimer’s disease in Idaho between 2000 and 2025 is expected to be the 15th largest at 22.2%. The number of older Americans with Alzheimer’s is projected to grow by 18.5% during that time.

As of last year, 27,000 Idaho residents over the age of 65 have been diagnosed with the condition. The number is estimated to increase to 33,000 by 2025.

The shares of people in Idaho who are 65 and older, 75 and older, as well as older people currently living with Alzheimer’s, are among the lowest in the county. As a consequence of the expected growth in Alzheimer’s cases in Idaho, Medicaid costs of caring for residents with the disease are expected to climb between 2020 and 2025 by 31.2%, the fourth highest increase in the country.

To determine the states where Alzheimer’s is soaring, 24/7 Wall St. reviewed the projected increase in the number of Americans 65 and older with Alzheimer’s disease between 2020 and 2025 in every state from the 2021 Alzheimer’s Association’s Alzheimer’s disease Facts and Figures report. These are the states where Alzheimer’s is expected to increase significantly.

StatePeople 65+ with Alzheimer’s: 2020Est. people 65+ with Alzheimer’s: 2025Percentage increasePct. of population 65+Pct. of population 65+ with Alzheimer’sNorth Dakota15,00016,0006.7%14.9%13.3%Missouri120,000130,0008.3%16.5%11.9%Wisconsin120,000130,0008.3%16.5%12.6%New Jersey190,000210,00010.5%15.9%13.5%Iowa66,00073,00010.6%16.7%12.6%South Dakota18,00020,00011.1%16.3%12.7%New York410,000460,00012.2%16.1%13.0%Rhode Island24,00027,00012.5%16.8%13.5%Kansas55,00062,00012.7%15.4%12.2%West Virginia39,00044,00012.8%19.4%11.1%Illinois230,000260,00013.0%15.2%11.8%Oklahoma67,00076,00013.4%15.3%11.1%Ohio220,000250,00013.6%16.7%11.3%Connecticut80,00091,00013.8%16.8%13.3%Mississippi57,00065,00014.0%15.4%12.4%Nebraska35,00040,00014.3%15.4%11.9%Pennsylvania280,000320,00014.3%17.8%12.3%Alabama96,000110,00014.6%16.5%11.9%Kentucky75,00086,00014.7%16.0%10.6%Massachusetts130,000150,00015.4%16.2%11.7%Arkansas58,00067,00015.5%16.6%11.6%Michigan190,000220,00015.8%16.7%11.4%North Carolina180,000210,00016.7%15.9%11.1%Tennessee120,000140,00016.7%16.0%11.2%Washington120,000140,00016.7%15.1%10.7%Indiana110,000130,00018.2%15.4%10.7%Maryland110,000130,00018.2%15.0%12.2%Louisiana92,000110,00019.6%15.0%13.2%Hawaii29,00035,00020.7%17.8%11.4%Maine29,00035,00020.7%20.0%10.8%Colorado76,00092,00021.1%13.8%9.8%Delaware19,00023,00021.1%18.2%10.9%Minnesota99,000120,00021.2%15.4%11.5%California690,000840,00021.7%14.0%12.6%Oregon69,00084,00021.7%17.2%9.7%Idaho27,00033,00022.2%15.4%10.2%Texas400,000490,00022.5%12.3%11.6%Montana22,00027,00022.7%18.2%11.5%New Hampshire26,00032,00023.1%17.5%11.0%New Mexico43,00053,00023.3%16.9%12.2%Utah34,00042,00023.5%10.8%10.2%Florida580,000720,00024.1%20.1%13.8%South Carolina95,000120,00026.3%17.2%11.0%Georgia150,000190,00026.7%13.5%10.7%Virginia150,000190,00026.7%15.0%11.8%Alaska8,50011,00029.4%11.2%10.3%Wyoming10,00013,00030.0%15.7%10.9%Nevada49,00064,00030.6%15.4%10.7%Vermont13,00017,00030.8%18.8%11.1%Arizona150,000200,00033.3%17.1%12.4%

Disclaimer: This content is distributed by The Center Square